Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Opposite trends in the consumption of manufactured and roll-your-own cigarettes in Spain (1991-2020)

  • Fu, Marcela|||0000-0002-4962-0927
  • Martínez-Sánchez, José M.|||0000-0002-9632-5701
  • Clèries, Ramon|||0000-0002-3637-4747
  • Villalbí, Joan Ramón|||0000-0001-6915-2545
  • Daynard, Richard A.
  • Connolly, Gregory N.
  • Fernández, Esteve|||0000-0003-4239-723X
Objective: The aim of this study is to describe trends in the consumption of manufactured and roll-your-own cigarettes between 1991 and 2012 in Spain, and to project these trends up to 2020. Methods: We estimated daily consumption per capita during 1991-2012 using data on sales of manufactured cigarettes (20-packs) and rolling tobacco (kg) from the Tobacco Market Commission, and using data of the Spanish adult population from the National Statistics Institute. We considered different weights (0.5, 0.8 and 1 g) to compute the number of rolled cigarettes per capita. We computed the annual per cent of change and assessed possible changes in trends using joinpoint regression, and projected the consumption up to 2020 using Bayesian methods. Results: Daily consumption per capita of manufactured cigarettes decreased on average by 3.0% per year in 1991-2012, from 7.6 to 3.8 units, with three trend changes. However, daily consumption per capita of roll-your-own cigarettes increased on average by 14.1% per year, from 0.07 to 0.92 units of 0.5 g, with unchanged trends. Together, daily consumption per capita decreased between 2.9% and 2.5%, depending on the weight of the roll-your-own cigarettes. Projections up to 2020 indicate a decrease of manufactured cigarettes (1.75 units per capita) but an increase of roll-your-own cigarettes (1.25 units per capita). Conclusions: While the consumption per capita of manufactured cigarettes has decreased in the past years in Spain, the consumption of roll-your-own cigarettes has increased at an annual rate around 14% over the past years. Whereas a net decrease in cigarette consumption is expected in the future, use of roll-your-own cigarettes will continue to increase.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of the Spanish smoke-free legislation on adult, non-smoker exposure to secondhand smoke, Cross-sectional surveys before (2004) and after (2012) legislation

  • Sureda, Xisca|||0000-0002-6262-2257
  • Martínez-Sánchez, José M.|||0000-0002-9632-5701
  • Fu, Marcela|||0000-0002-4962-0927
  • Pérez Ortuño, Raúl|||0000-0002-1837-5447
  • Martínez, Cristina|||0000-0002-9368-1356
  • Carabasa, Esther
  • López Medina, María José|||0000-0003-4402-2239
  • Saltó, Esteve|||0000-0002-6739-8936
  • Pascual, José A.|||0000-0003-0837-4026
  • Fernández, Esteve|||0000-0003-4239-723X
Background: In 2006, Spain implemented a national smoke-free legislation that prohibited smoking in enclosed public places and workplaces (except in hospitality venues). In 2011, it was extended to all hospitality venues and selected outdoor areas (hospital campuses, educational centers, and playgrounds). The objective of the study is to evaluate changes in exposure to secondhand smoke among the adult non-smoking population before the first law (2004-05) and after the second law (2011-12). Methods: Repeated cross-sectional survey (2004-2005 and 2011-2012) of a representative sample of the adult (≥16 years) non-smoking population in Barcelona, Spain. We assess self-reported exposure to secondhand smoke (at home, the workplace, during leisure time, and in public/private transportation vehicles) and salivary cotinine concentration. Results: Overall, the self-reported exposure to secondhand smoke fell from 75.7% (95%CI: 72.6 to 78.8) in 2004-05 to 56.7% (95%CI: 53.4 to 60.0) in 2011-12. Self-reported exposure decreased from 32.5% to 27.6% (215.1%, p<0.05) in the home, from 42.9% to 37.5% (212.6%, p = 0.11) at work/education venues, from 61.3% to 38.9% (236.5%, p<0.001) during leisure time, and from 12.3% to 3.7% (269.9%, p<0.001) in public transportation vehicles. Overall, the geometric mean of the salivary cotinine concentration in adult non-smokers fell by 87.2%, from 0.93 ng/mL at baseline to 0.12 ng/mL after legislation (p<0.001). Conclusions: Secondhand smoke exposure among non-smokers, assessed both by self-reported exposure and salivary cotinine concentration, decreased after the implementation of a stepwise, comprehensive smoke-free legislation. There was a high reduction in secondhand smoke exposure during leisure time and no displacement of secondhand smoke exposure at home. © 2014 Sureda et al.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain)

  • Corral, Julieta
  • Espinàs, Josep Alfons
  • Cots Reguant, Francesc|||0000-0003-0238-8902
  • Pareja, Laura
  • Solà, Judit
  • Font, Rebeca
  • Borras, Josep M|||0000-0001-7330-6308
Assessing of the costs of treating disease is necessary to demonstrate cost-effectiveness and to estimate the budget impact of new interventions and therapeutic innovations. However, there are few comprehensive studies on resource use and costs associated with lung cancer patients in clinical practice in Spain or internationally. The aim of this paper was to assess the hospital cost associated with lung cancer diagnosis and treatment by histology, type of cost and stage at diagnosis in the Spanish National Health Service. A retrospective, descriptive analysis on resource use and a direct medical cost analysis were performed. Resource utilisation data were collected by means of patient files from nine teaching hospitals. From a hospital budget impact perspective, the aggregate and mean costs per patient were calculated over the first three years following diagnosis or up to death. Both aggregate and mean costs per patient were analysed by histology, stage at diagnosis and cost type. A total of 232 cases of lung cancer were analysed, of which 74.1% corresponded to non-small cell lung cancer (NSCLC) and 11.2% to small cell lung cancer (SCLC); 14.7% had no cytohistologic confirmation. The mean cost per patient in NSCLC ranged from 13,218 Euros in Stage III to 16,120 Euros in Stage II. The main cost components were chemotherapy (29.5%) and surgery (22.8%). Advanced disease stages were associated with a decrease in the relative weight of surgical and inpatient care costs but an increase in chemotherapy costs. In SCLC patients, the mean cost per patient was 15,418 Euros for limited disease and 12,482 Euros for extensive disease. The main cost components were chemotherapy (36.1%) and other inpatient costs (28.7%). In both groups, the Kruskall-Wallis test did not show statistically significant differences in mean cost per patient between stages. This study provides the costs of lung cancer treatment based on patient file reviews, with chemotherapy and surgery accounting for the major components of costs. This cost analysis is a baseline study that will provide a useful source of information for future studies on cost-effectiveness and on the budget impact of different therapeutic innovations in Spain.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-term costs of colorectal cancer treatment in Spain

  • Corral, Julieta
  • Castells, Xavier|||0000-0002-2528-0382
  • Molins, Eduard
  • Chiarello, Pietro
  • Borras, Josep M|||0000-0001-7330-6308
  • Cots Reguant, Francesc|||0000-0003-0238-8902
Assessing the long-term cost of colorectal cancer (CRC) increases our understanding of the disease burden. The aim of this paper is to estimate the long-term costs of CRC care by stage at diagnosis and phase of care in the Spanish National Health Service. Retrospective study on resource use and direct medical cost of a cohort of 699 patients diagnosed and treated for CRC in 2000-2006, with follow-up until 30 June 2011, at Hospital del Mar (Barcelona). The Kaplan-Meier sample average estimator was used to calculate observed 11-year costs, which were then extrapolated to 16 years. Bootstrap percentile confidence intervals were calculated for the mean long-term cost per patient by stage. Phase-specific, long-term costs for the entire CRC cohort were also estimated. With regard to stage at diagnosis, the mean long-term cost per patient ranged from €20,708 (in situ) to €47,681 (stage III). The estimated costs increased at more advanced stages up to stage III and then substantially decreased in stage IV. In terms of treatment phase, the mean cost of the initial period represented 24.8 % of the total mean long-term cost, whereas the cost of continuing and advanced care phases represented 16.9 and 58.3 %, respectively. This study is the first to provide long-term cost estimates for CRC treatment, by stage at diagnosis and phase of care, based on data from clinical practice in Spain, and it will contribute useful information for future studies on cost-effectiveness and budget impact of different therapeutic innovations in Spain.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Changes in the prevalence of tobacco consumption and the profile of Spanish smokers after a comprehensive smoke-free policy

  • Pérez Ríos, Mónica
  • Fernández, Esteve|||0000-0003-4239-723X
  • Schiaffino, Anna|||0000-0001-8787-2634
  • Nebot, Manel
  • López Medina, María José|||0000-0003-4402-2239
Background: A partial smoke-free regulation in Spain was introduced on January 1, 2006, which was subsequently amended to introduce a comprehensive smoke-free policy from 2 January 2011 onward. The objective of this study was to compare the prevalence of tobacco consumption in Spain and the profile of smokers before (2006) and after (2011) the comprehensive smoking ban passed in 2010. Methods: Two independent, cross-sectional, population-based surveys were carried out among the adult (≥ 18 years old) Spanish population in 2006 and 2011 through telephone interviews. Both surveys used the same methods and questionnaire. Nicotine dependence was assessed with the Fagerström Test for nicotine dependence and readiness to quit according to the stages of change. Results: The prevalence of tobacco consumption showed a nonsignificant decrease from 23.4% in 2006 to 20.7% in 2011. No changes were observed in nicotine dependence or readiness to quit. In 2011, most smokers (76%) showed low nicotine dependence and were mainly in the precontemplation stage (72%). Conclusions: The prevalence of smokers has slightly decreased since the introduction of the total smoking ban in Spain. No differences were found in nicotine dependence or readiness to quit.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Secondhand smoke in outdoor settings, Smokers' consumption, non-smokers' perceptions, and attitudes towards smoke-free legislation in Spain

  • Sureda, Xisca|||0000-0002-6262-2257
  • Fernández, Esteve|||0000-0003-4239-723X
  • Martínez-Sánchez, José M.|||0000-0002-9632-5701
  • Fu, Marcela|||0000-0002-4962-0927
  • López Medina, María José|||0000-0003-4402-2239
  • Martínez, Cristina|||0000-0002-9368-1356
  • Saltó, Esteve|||0000-0002-6739-8936
Objective: To describe where smokers smoke outdoors, where non-smokers are exposed outdoors to secondhand smoke (SHS), and attitudes towards smoke-free outdoor areas after the implementation of national smoke-free legislation. Design: This cross-sectional study was conducted between June 2011 and March 2012 (n=1307 participants). Setting: Barcelona, Spain. Participants: Representative, random sample of the adult (≥16 years) population. Primary and secondary outcomes: Proportion of smoking and prevalence of exposure to SHS in the various settings according to type of enclosure. Percentages of support for outdoor smoke-free policies according to smoking status. Results: Smokers reported smoking outdoors most in bars and restaurants (54.8%), followed by outdoor places at work (46.8%). According to non-smokers, outdoor SHS exposure was highest at home (42.5%) and in bars and restaurants (33.5%). Among non-smoking adult students, 90% claimed exposure to SHS on university campuses. There was great support for banning smoking in the majority of outdoor areas, which was stronger among non-smokers than smokers. Over 70% of participants supported smoke-free playgrounds, school and high school courtyards, and the grounds of healthcare centres. Conclusions: Extending smoking bans to selected outdoor settings should be considered in further tobacco control interventions to protect non-smokers from SHS exposure and to establish a positive model for youth. The majority of public support for some outdoor smoke-free areas suggests that it is feasible to extend smoking bans to additional outdoor settings.